Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-130,980
Closed -$5.28M 389
2015
Q4
$5.28M Buy
130,980
+47,152
+56% +$1.89M 0.39% 84
2015
Q3
$3.18M Buy
83,828
+11,282
+16% +$476K 0.25% 112
2015
Q2
$2.88M Sell
72,546
-236
-0.3% -$7.35K 0.2% 127
2015
Q1
$1.95M Buy
72,782
+7,036
+11% +$199K 0.13% 155
2014
Q4
$1.93M Sell
65,746
-2,148
-3% -$53K 0.15% 148
2014
Q3
$1.37M Buy
67,894
+3,450
+5% +$66.6K 0.12% 175
2014
Q2
$1.08M Buy
64,444
+2,776
+5% +$39.3K 0.09% 200
2014
Q1
$918K Sell
61,668
-1,158
-2% -$17.8K 0.08% 214
2013
Q4
$919K Sell
62,826
-5,327
-8% -$85.8K 0.09% 214
2013
Q3
$1.17M Sell
68,153
-2,533
-4% -$37.6K 0.13% 181
2013
Q2
$820K Buy
+70,686
New +$810K 0.1% 200

Other funds holding AMED

Burney Company's AMED Position: Q1 2016 in Review

Burney Company sold out of Amedisys (AMED) in Q1 2016, closing a stake of 130,980 shares — an estimated $5.28M sold.

Burney Company first reported a position in AMED in Q2 2013 and held it in 11 quarters. The position peaked at $5.28M in Q4 2015. 169 funds tracked by Wall St. Rank hold AMED as of Q1 2016.

  • Burney Company reported no remaining Amedisys position as of Q1 2016 after selling out during the quarter.
  • Burney Company sold 130,980 Amedisys shares in Q1 2016, an estimated $5.28M.
  • Burney Company first reported a position in Amedisys in Q2 2013 and held it in 11 quarters.
  • Burney Company's Amedisys position peaked at $5.28M in Q4 2015.
  • 169 funds tracked by Wall St. Rank held Amedisys as of Q1 2016.

Based on Burney Company's 13F filing for Q1 2016, filed 2 May 2016.